Adverse effects · People with any one of a mixed group of cancers
Hyperbaric oxygen leads to higher adverse effects compared with air breathing (high certainty).
1 finding from 1 review
Diarrhoea · participants with cancer treated with chemotherapy
Probiotics may leads to lower any diarrhoea compared with placebo (low certainty).
1 finding from 1 review
Quality of life ‐ not measured · participants with cancer treated with chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diarrhoea (grade 2+) · participants with cancer treated with chemotherapy
Probiotics showed no clear difference in diarrhoea grade 2 or higher compared with placebo (low certainty).
1 finding from 1 review
Grade 3 to 4 diarrhoea · participants with cancer treated with chemotherapy
Probiotics showed no clear difference in diarrhoea grade 3 or higher compared with placebo (low certainty).
1 finding from 1 review
Diarrhoea grade 4 · participants with cancer treated with chemotherapy
Probiotics showed no clear difference in diarrhoea grade 4 compared with placebo (low certainty).
1 finding from 1 review
Time to rescue medication ‐ not measured · participants with cancer treated with chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Requiring rescue medication for diarrhoea · participants with cancer treated with chemotherapy
1 finding from 1 review
Adverse events · participants with cancer treated with chemotherapy
1 finding from 1 review
All‐cause mortality · participants with cancer treated with chemotherapy
1 finding from 1 review
Overall survival · advanced pancreatic cancer
Anti‐cancer therapy showed no clear difference in overall survival compared with best supportive care (moderate certainty).
1 finding from 1 review
Overall survival ‐ Gemcitabine plus topoisomerase inhibitor · advanced pancreatic cancer
Gemcitabine combinations showed no clear difference in overall survival ‐ Gemcitabine plus topoisomerase inhibitor compared with gemcitabine alone (high certainty).
1 finding from 1 review
Overall survival ‐ Gemcitabine plus taxane · advanced pancreatic cancer
Gemcitabine combinations leads to lower overall survival ‐ Gemcitabine plus taxane compared with gemcitabine alone (high certainty).
1 finding from 1 review
Overall survival ‐ Gemcitabine plus other combinations of chemotherapy · advanced pancreatic cancer
Gemcitabine combinations may leads to lower overall survival ‐ Gemcitabine plus other combinations of chemotherapy compared with gemcitabine alone (low certainty).
1 finding from 1 review
Overall survival ‐ Gemcitabine plus other agent(s) · advanced pancreatic cancer
Gemcitabine combinations showed no clear difference in overall survival ‐ Gemcitabine plus other agent(s) compared with gemcitabine alone (low certainty).
1 finding from 1 review
Overall survival · advanced pancreatic cancer
Fluoropyrimidine combinations showed no clear difference in overall survival compared with fluoropyrimidine alone (low certainty).
1 finding from 1 review
Overall survival ‐ 5FU · advanced pancreatic cancer
Various types of chemotherapy probably leads to higher overall survival ‐ 5FU compared with gemcitabine (moderate certainty).
1 finding from 1 review
Overall survival ‐ FOLFIRINOX · advanced pancreatic cancer
Various types of chemotherapy probably leads to lower overall survival ‐ FOLFIRINOX compared with gemcitabine (moderate certainty).
1 finding from 1 review
Overall survival ‐ Fixed dose rate gemcitabine · advanced pancreatic cancer
Various types of chemotherapy leads to lower overall survival ‐ Fixed dose rate gemcitabine compared with gemcitabine (high certainty).
1 finding from 1 review
Overall survival ‐ CO‐101 · advanced pancreatic cancer
Various types of chemotherapy showed no clear difference in overall survival ‐ CO‐101 compared with gemcitabine (moderate certainty).
1 finding from 1 review